Juwei Mu

1.0k total citations
74 papers, 654 citations indexed

About

Juwei Mu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Juwei Mu has authored 74 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 26 papers in Surgery and 26 papers in Oncology. Recurrent topics in Juwei Mu's work include Lung Cancer Diagnosis and Treatment (34 papers), Esophageal Cancer Research and Treatment (16 papers) and Gastric Cancer Management and Outcomes (16 papers). Juwei Mu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (34 papers), Esophageal Cancer Research and Treatment (16 papers) and Gastric Cancer Management and Outcomes (16 papers). Juwei Mu collaborates with scholars based in China, United States and Japan. Juwei Mu's co-authors include Qi Xue, Shugeng Gao, Jie He, Yousheng Mao, Yushun Gao, Fengwei Tan, Dali Wang, Shugeng Gao, Dali Wang and Kelin Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and American Journal of Epidemiology.

In The Last Decade

Juwei Mu

65 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juwei Mu China 15 426 292 164 54 47 74 654
Yu Ohkura Japan 17 346 0.8× 454 1.6× 160 1.0× 28 0.5× 25 0.5× 78 700
Han J. Bonenkamp Netherlands 14 335 0.8× 352 1.2× 135 0.8× 42 0.8× 60 1.3× 45 658
Sunao Uemura Japan 15 330 0.8× 341 1.2× 265 1.6× 18 0.3× 38 0.8× 77 645
Valerio Di Scioscio Italy 15 417 1.0× 213 0.7× 96 0.6× 72 1.3× 59 1.3× 34 639
Kentaro Hara Japan 14 276 0.6× 268 0.9× 229 1.4× 26 0.5× 38 0.8× 89 558
Neil A. Collier Australia 16 371 0.9× 545 1.9× 174 1.1× 32 0.6× 41 0.9× 37 749
Massimo Monacelli Italy 16 123 0.3× 474 1.6× 152 0.9× 38 0.7× 65 1.4× 49 808
Ángel Salvatierra Spain 14 410 1.0× 264 0.9× 98 0.6× 20 0.4× 72 1.5× 28 620
Marcus Fernando Kodama Pertille Ramos Brazil 18 682 1.6× 380 1.3× 343 2.1× 25 0.5× 47 1.0× 97 900
Claudio Mauriello Italy 20 160 0.4× 670 2.3× 154 0.9× 35 0.6× 41 0.9× 37 900

Countries citing papers authored by Juwei Mu

Since Specialization
Citations

This map shows the geographic impact of Juwei Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juwei Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juwei Mu more than expected).

Fields of papers citing papers by Juwei Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juwei Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juwei Mu. The network helps show where Juwei Mu may publish in the future.

Co-authorship network of co-authors of Juwei Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Juwei Mu. A scholar is included among the top collaborators of Juwei Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juwei Mu. Juwei Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Qiuxiong, Ying Li, Juwei Mu, et al.. (2025). Dehydrocostus lactone induces apoptosis and mitophagy in gastric cancer cells through the ROS-mediated mitochondrial pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 399(3). 3603–3618. 1 indexed citations
3.
Qian, Hong, et al.. (2025). Patient-reported outcomes after lobectomy vs. segmentectomy for early-stage non-small cell lung cancer. Surgical Endoscopy. 39(11). 7566–7575. 1 indexed citations
4.
Dai, Yaomin, Qiang Xia, Zijun Mao, et al.. (2025). Sustainable bioplastics build on d -xylose cores: from backup to the center stage. Green Chemistry. 27(17). 4464–4488. 3 indexed citations
5.
Han, Rui, Qinghao Chen, Yan-Cheng Wang, et al.. (2025). IRF8 and CD2 are potential targets of immunotherapy in non-small cell lung cancer. Journal of Thoracic Disease. 17(3). 1169–1184.
6.
Yi, Hang, Hong Qian, Lu Liu, et al.. (2024). Patient-reported outcomes in lung cancer surgery: A narrative review. Asian Journal of Surgery. 48(1). 40–48. 3 indexed citations
7.
Han, Rui, Hong Qian, Chenguang Zhao, et al.. (2024). NLR, MLR, and PLR are adverse prognostic variables for sleeve lobectomy within non‐small cell lung cancer. Thoracic Cancer. 15(24). 1792–1804. 3 indexed citations
8.
Qian, Hong, Rui Han, Fuquan Wang, et al.. (2024). Clinical characteristics and prognosis of primary thymic adenocarcinoma: A single‐center retrospective analysis. Thoracic Cancer. 15(24). 1815–1821. 1 indexed citations
10.
Li, Jialin, Juwei Mu, Feng Li, et al.. (2023). Silva Classification System for HPV-Related EAC of Stage I ∼ IIIc1p Cervical Adenocarcinoma and Its Effect on Prognosis and Survival. International Journal of Radiation Oncology*Biology*Physics. 117(2). e526–e526. 1 indexed citations
11.
Yuan, Zuyang, Xinfeng Wang, Yin Li, et al.. (2020). Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?. Cancer Communications. 41(1). 3–15. 22 indexed citations
12.
Yu, Xiangyang, Shugeng Gao, Qi Xue, et al.. (2020). Development of a predictive nomogram for cause-specific mortality in surgically resected early-stage oesophageal cancer: a Surveillance, Epidemiology, and End Results (SEER) analysis. Journal of Thoracic Disease. 12(5). 2583–2594. 3 indexed citations
13.
Wang, Yalong, Songhua Cai, Qi Xue, et al.. (2020). Treatment outcomes of patients with tracheobronchial mucoepidermoid carcinoma compared with those with adenoid cystic carcinoma. European Journal of Surgical Oncology. 46(10). 1888–1895. 12 indexed citations
14.
Gao, Shugeng, Yalong Wang, Qi Xue, et al.. (2019). Esophageal Squamous Cell Carcinoma Involving the Lip, Back and Hip. Journal of Thoracic Oncology. 14(9). 1672–1674. 1 indexed citations
15.
Li, Ning, Fengwei Tan, Bin Qiu, et al.. (2018). [Comparison of lung cancer surgery in China, 2005 vs. 2015].. PubMed. 40(4). 300–302. 2 indexed citations
16.
Yang, Ding, Yousheng Mao, Jie He, et al.. (2018). Long-term survival of the middle and lower thoracic esophageal cancer patients after surgical treatment through left or right thoracic approach. Journal of Thoracic Disease. 10(5). 2648–2655. 13 indexed citations
17.
Gao, Shugeng, Yousheng Mao, Juwei Mu, et al.. (2016). Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers. Scientific Reports. 6(1). 23252–23252. 47 indexed citations
18.
Mu, Juwei, Shugeng Gao, Qi Xue, et al.. (2016). The impact of operative approaches on outcomes of middle and lower third esophageal squamous cell carcinoma. Journal of Thoracic Disease. 8(12). 3588–3595. 4 indexed citations
19.
Mu, Juwei, Shugeng Gao, Qi Xue, et al.. (2015). A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer. Chinese Medical Journal. 128(20). 2731–2735. 41 indexed citations
20.
Rebholz, Casey M., Dongfeng Gu, Jing Chen, et al.. (2012). Physical Activity Reduces Salt Sensitivity of Blood Pressure: The Genetic Epidemiology Network of Salt Sensitivity Study. American Journal of Epidemiology. 176(suppl 7). S106–S113. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026